Cargando…
Microbiology of the American Smokeless Tobacco
ABSTRACT: Smokeless tobacco products (STP) contain diverse microbial communities that contribute to the formation of harmful chemical byproducts. This is concerning since 300 million individuals around the globe are users of smokeless tobacco. Significant evidence has shown that microbial metabolic...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190171/ https://www.ncbi.nlm.nih.gov/pubmed/34110473 http://dx.doi.org/10.1007/s00253-021-11382-z |
_version_ | 1783705639267074048 |
---|---|
author | Rivera, A. J. Tyx, R. E. |
author_facet | Rivera, A. J. Tyx, R. E. |
author_sort | Rivera, A. J. |
collection | PubMed |
description | ABSTRACT: Smokeless tobacco products (STP) contain diverse microbial communities that contribute to the formation of harmful chemical byproducts. This is concerning since 300 million individuals around the globe are users of smokeless tobacco. Significant evidence has shown that microbial metabolic activities mediate the formation of carcinogens during manufacturing. In recent years, studies have revealed a series of additional health impacts that include lesions and inflammation of the oral mucosa and the gastrointestinal tract, as well as alterations of the endogenous microbiota. These findings are due to recent developments in molecular technologies that allowed researchers to better examine the microbial component of these products. This new information illustrates the scale of the STP microbiota and its diversity in the finished product that is sold for consumption. Additionally, the application of metagenomics and metatranscriptomics has provided the tools to look at phylogenies across bacterial, viral, and eukaryotic groups, their functional capacities, and viability. Here we present key examples of tobacco microbiology research that utilizes newer approaches and strategies to define the microbial component of smokeless tobacco products. We also highlight challenges in these approaches, the knowledge gaps being filled, and those gaps that warrant further study. A better understanding of the microbiology of STP brings vast public health benefits. It will provide important information for the product consumer, impact manufacturing practices, and provide support for the development of attainable and more meaningful regulatory goals. KEY POINTS: Newer technologies allowed quicker and more comprehensive identification of microbes in tobacco samples, encapsulating microorganisms difficult or impossible to culture. Current research in smokeless tobacco microbiology is filling knowledge gaps previously unfilled due to the lack of suitable approaches. The microbial ecology of smokeless tobacco presents a clearer picture of diversity and variability not considered before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11382-z. |
format | Online Article Text |
id | pubmed-8190171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81901712021-06-10 Microbiology of the American Smokeless Tobacco Rivera, A. J. Tyx, R. E. Appl Microbiol Biotechnol Mini-Review ABSTRACT: Smokeless tobacco products (STP) contain diverse microbial communities that contribute to the formation of harmful chemical byproducts. This is concerning since 300 million individuals around the globe are users of smokeless tobacco. Significant evidence has shown that microbial metabolic activities mediate the formation of carcinogens during manufacturing. In recent years, studies have revealed a series of additional health impacts that include lesions and inflammation of the oral mucosa and the gastrointestinal tract, as well as alterations of the endogenous microbiota. These findings are due to recent developments in molecular technologies that allowed researchers to better examine the microbial component of these products. This new information illustrates the scale of the STP microbiota and its diversity in the finished product that is sold for consumption. Additionally, the application of metagenomics and metatranscriptomics has provided the tools to look at phylogenies across bacterial, viral, and eukaryotic groups, their functional capacities, and viability. Here we present key examples of tobacco microbiology research that utilizes newer approaches and strategies to define the microbial component of smokeless tobacco products. We also highlight challenges in these approaches, the knowledge gaps being filled, and those gaps that warrant further study. A better understanding of the microbiology of STP brings vast public health benefits. It will provide important information for the product consumer, impact manufacturing practices, and provide support for the development of attainable and more meaningful regulatory goals. KEY POINTS: Newer technologies allowed quicker and more comprehensive identification of microbes in tobacco samples, encapsulating microorganisms difficult or impossible to culture. Current research in smokeless tobacco microbiology is filling knowledge gaps previously unfilled due to the lack of suitable approaches. The microbial ecology of smokeless tobacco presents a clearer picture of diversity and variability not considered before. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11382-z. Springer Berlin Heidelberg 2021-06-10 2021 /pmc/articles/PMC8190171/ /pubmed/34110473 http://dx.doi.org/10.1007/s00253-021-11382-z Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mini-Review Rivera, A. J. Tyx, R. E. Microbiology of the American Smokeless Tobacco |
title | Microbiology of the American Smokeless Tobacco |
title_full | Microbiology of the American Smokeless Tobacco |
title_fullStr | Microbiology of the American Smokeless Tobacco |
title_full_unstemmed | Microbiology of the American Smokeless Tobacco |
title_short | Microbiology of the American Smokeless Tobacco |
title_sort | microbiology of the american smokeless tobacco |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190171/ https://www.ncbi.nlm.nih.gov/pubmed/34110473 http://dx.doi.org/10.1007/s00253-021-11382-z |
work_keys_str_mv | AT riveraaj microbiologyoftheamericansmokelesstobacco AT tyxre microbiologyoftheamericansmokelesstobacco |